Radioterapia
Revisão | Passado, presente e futuro da cardiotoxicidade induzida por radiação.
6 Dez, 2021 | 16:13hVídeo: Radiation Therapy and Cardiovascular Disease | JACC: CardioOncology Author Discussion
Conteúdos relacionados:
Radiation‐induced cardiovascular disease: review of an underrecognized pathology.
Short review: How to diagnose and manage radiation therapy cardiotoxicity
Cohort Study: Cardiac Radiation Dose, Cardiac Disease, and Mortality in Patients with Lung Cancer
Avanços na radioterapia para câncer de mama: implicações para as práticas atuais e futuras.
30 Nov, 2021 | 12:03h
Comentário no Twitter
Advances in #BreastCancer radiotherapy allow shorter regimens and reduced toxicities. This #JCOOP Clinical review summarizes the latest evidence in #radonc for #bcsm @CshahMD ➡️ https://t.co/JxvU5FSQlv pic.twitter.com/GOcwAFJzRm
— Journal of Clinical Oncology (@JCO_ASCO) October 31, 2021
Resultados de longo prazo de estudo randomizado | Quimioradioterapia com indução ou quimioterapia de consolidação como terapia neoadjuvante total para pacientes com câncer retal
19 Nov, 2021 | 12:48hChemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Patients With Locally Advanced Rectal Cancer: Long-term Results of the CAO/ARO/AIO-12 Randomized Clinical Trial – JAMA Oncology (gratuito por tempo limitado)
Entrevista com o autor: Chemoradiotherapy Plus Induction or Consolidation Chemotherapy for Locally Advanced Rectal Cancer – JAMA Oncology
Comentário no Twitter
Secondary analysis of 311 pts on ARO-12 trial of variant approaches to total neoadjuvant therapy (TNT) w/combo of chemo & concurrent chemoradiation (CRT) for rectal cancer shows best results w/up-front CRT then chemo & resection led to best results https://t.co/7cpv5cb1Fr #CRCSM pic.twitter.com/bxfz9Fi5OB
— JAMA Oncology (@JAMAOnc) November 18, 2021
M-A | Comparação entre desfechos de quimiorradioterapia neoadjuvante e quimioterapia neoadjuvante em pacientes com câncer esofágico localmente avançado.
8 Nov, 2021 | 12:24hEstudo randomizado | Irradiação eletiva de linfonodo mamário interno não aumenta a sobrevida livre de doença ou a sobrevida geral na maioria das mulheres com câncer de mama com linfonodo acometido.
27 Out, 2021 | 12:31hEffect of Elective Internal Mammary Node Irradiation on Disease-Free Survival in Women With Node-Positive Breast Cancer: A Randomized Phase 3 Clinical Trial – JAMA Oncology (gratuito por tempo limitado)
Comentário: No Survival Benefit for Internal Mammary Node Irradiation in Breast Cancer — Women with medially or centrally located tumors may be candidates, however, says researcher – MedPage Today (necessário cadastro gratuito)
Comentário no Twitter
Phase III randomized study evaluated the role of internal mammary node irradiation (IMNI) in node-positive #breastcancer. IMNI did not improve the DFS in unselected patients, but did improve DFS in patients with medially or centrally located tumors https://t.co/tw4ZrHn5wn pic.twitter.com/34ye3TR9MA
— JAMA Oncology (@JAMAOnc) October 25, 2021
Radioterapia | Dicas clínicas para a atenção primária.
22 Out, 2021 | 12:12hRadiotherapy: Clinical pearls for primary care – Canadian Family Physician
Estudo de coorte | Mulheres tratadas com radioterapia para câncer de mama do lado esquerdo tiveram mais que o dobro de risco de doença arterial coronariana em comparação com mulheres que receberam o mesmo tratamento, mas para o lado direito.
1 Out, 2021 | 21:55hComentários:
CAD in Young Women After Radiation Therapy for Breast Cancer – American College of Cardiology
Comentário no Twitter
According to a study from #JACCCardioOnc, women with left-sided breast cancer undergoing radiation therapy between 1985 and 2008 had over twice the risk of subsequent #cvCAD compared to women with right-sided breast cancer. Learn more here: https://t.co/5q9tToSSRp #CardioOnc
— American College of Cardiology (@ACCinTouch) September 22, 2021
Diretriz para a vigilância e os cuidados de sobrevivência de pacientes após tratamento curativo de câncer colônico e retal.
17 Set, 2021 | 12:23hConteúdo relacionado: Study: Assessment of a Watch-and-Wait Strategy for Rectal Cancer in Patients With a Complete Response After Neoadjuvant Therapy
Comentário no Twitter
Clinical Practice Guidelines – Surveillance and Survivorship shown in #DCRJournal visual abstract by @ianmpaquette @JMigaly @ASCRS_1. What do you think? https://t.co/e3kADOerpq@JISBMD @ConorDelaneyMD @justinmaykel @KarimAlavi @KyleCologne @dubaicolorectal @SamAtallahMD pic.twitter.com/wOhu0Mby60
— DCRjournal (@DCRjournal) May 9, 2021
Revisão sistemática | Radiação mamária parcial vs. radioterapia mamária total para câncer de mama precoce.
17 Set, 2021 | 11:50h
Comentário no Twitter
For women with early-stage #BreastCancer, how does giving radiotherapy to part of the breast compare with giving #radiotherapy to the whole breast? The latest Cochrane Review from @CochraneBCancer brings together nine studies, which involved 15,187 women: https://t.co/fVuSrSDAZM pic.twitter.com/QOufZYSH5I
— Cochrane UK (@CochraneUK) September 3, 2021
Relatório de longo prazo de estudo avaliando o uso da radiação após cirurgia excisional de carcinoma ductal in situ de baixo risco.
14 Set, 2021 | 14:11h
Comentário no Twitter
At 15 years, NRG-RTOG 9804 "good risk" breast #DCIS trial shows advantage of radiation therapy over observation to reduce #breastcancer risk https://t.co/l5OWVOb5Dg
#JCO #BCSM #radonc @NRGOnc; @MSK_RadOnc pic.twitter.com/TPAZRheoHT— ASCO Publications (@ASCO_pubs) September 10, 2021